The American Respiratory Care Foundation presented the Dr. Charles H. Hudson Award for Cardiopulmonary Public Health to the COPD Foundation Nov. 16 in Anaheim, CA. John Walsh, co-founder and president of the COPD Foundation, accepted the award on behalf of the COPD Foundation.
The American Respiratory Care Foundation is a nonprofit organization founded by the American Association for Respiratory Care (AARC) to provide funding for research in the field of pulmonology and respiratory care. The ceremony will take place at the AARC’s 2013 Congress in Anaheim, CA.
“All of us at the COPD Foundation are honored to receive the Hudson Award,” said Walsh. “This recognition by the prestigious Respiratory Care Foundation will enhance our efforts to bring greater awareness and detection and more effective treatments for COPD. Some 12 million people in the United States have been diagnosed with COPD, and experts estimate that just as many have the condition and don’t even know it. We are grateful to the Respiratory Care Foundation for the honor.”
Walsh, who is also co-founder and CEO of the Alpha-1 Foundation, received the Hudson Award as an individual in 2006 for his work on promoting better health, improved detection, and increased research on Alpha-1 Antitrypsin Deficiency, the most important known genetic cause of emphysema. COPD is an umbrella term that includes emphysema and chronic bronchitis.
The Dr. Charles H. Hudson Award for Cardiopulmonary Public Health is funded by donations from Hudson Respiratory Care, Inc. and was established in 1986 in honor of the company’s founder, Charles H. Hudson, DDS. The award is given in recognition of an individual’s or organization’s efforts to positively influence the public’s awareness of cardiopulmonary health and wellness.
Read the COPD Foundation press release.